The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

New research shows GRIN2A may be the first single gene capable of causing mental illness, challenging long-held beliefs about ...

Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.

The shadow of Alzheimer's disease looms large over our aging population. It is more than a memory disorder; it's a ...

As information zings from cell to cell inside the brain, bursts of electricity spur its transmission. At Cold Spring Harbor Laboratory (CSHL), scientists have turned their attention to the tiny pores ...

Total 3Q 2025 net product revenue of $171.0 million, representing 63% year-over-year growthAUVELITY® 3Q 2025 net product sales of $136.1 million, ...

Reports Major Clinical And Corporate Milestones As Phase 3 Alzheimer's Trial Advances Toward Completion. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced it ...

The MarketWatch News Department was not involved in the creation of this content. COLD SPRING HARBOR, N.Y., Oct. 29, 2025 /PRNewswire/ -- As information zings from cell to cell inside the brain, ...

As information zings from cell to cell inside the brain, bursts of electricity spur its transmission. At Cold Spring Harbor Laboratory (CSHL), scientists have turned their attention to the tiny pores ...

The Society for Neuroscience (SfN) will honor five leading researchers whose impactful work has transformed neuroscience — including the understanding of memory, synapse formation, social ...